Comparison of Different Prognostic Models for Predicting Cancer-Specific Survival in Bladder Transitional Cell Carcinoma

Reference

• Antoni S , FerlayJ, SoerjomataramI, ZnaorA, JemalA, BrayF. Bladder cancer incidence and mortality: a global overview and recent trends. Eur. Urol.71, 96–108 (2017).
   PubMed Web of Science ®Google Scholar
• Parkin DM . The global burden of urinary bladder cancer. Scand. J. Urol. Nephrol. Suppl. (218), 12–20 (2008).
   PubMedGoogle Scholar
• Siegel RL , MillerKD, JemalA. Cancer statistics, 2018. CA Cancer J. Clin.68(1), 7–30 (2018).
   PubMed Web of Science ®Google Scholar
• Chen C , HuL, ChenY, HouJ. The prognostic value of histological subtype in patients with metastatic bladder cancer. Oncotarget8, 28408–28417 (2017).
   PubMedGoogle Scholar
• Rusthoven KE , FlaigTW, RabenD, KavanaghBD. High incidence of lung cancer after non-muscle-invasive transitional cell carcinoma of the bladder: implications for screening trials. Clin. Lung Cancer9, 106–111 (2008).
   PubMed Web of Science ®Google Scholar
• Thoma C . Bladder cancer: better prediction of lymph node metastasis. Nat. Rev. Urol.13(6), 301 (2016).
   PubMedGoogle Scholar
• Burger M , CattoJW, DalbagniGet al. Epidemiology and risk factors of urothelial bladder cancer. Eur. Urol.63, 234–241 (2013).
   PubMed Web of Science ®Google Scholar
• Traxer O , PasquiF, GattegnoB, PearleMS. Technique and complications of transurethral surgery for bladder tumours. BJU Int.94, 492–496 (2004).
   PubMed Web of Science ®Google Scholar
• DeSantis CE , LinCC, MariottoABet al. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin.64, 252–271 (2014).
   PubMed Web of Science ®Google Scholar
• Wang G , McKenneyJK. Urinary bladder pathology: World Health Organization (WHO) classification and American Joint Committee on Cancer (AJCC) staging update. Arch. Pathol. Lab. Med. doi:10.5858/arpa.2017-0539-RA (2018) ( Epub ahead of print).
   Web of Science ®Google Scholar
• Dong F , ShenY, GaoFet al. Nomograms to predict individual prognosis of patients with primary small cell carcinoma of the bladder. J. Cancer9, 1152–1164 (2018).
   PubMed Web of Science ®Google Scholar
• Mackey JR , AuHJ, HughJ, VennerP. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J. Urol.159, 1624–1629 (1998).
   PubMed Web of Science ®Google Scholar
• Wiesner C , SalzerA, ThomasCet al. Cancer-specific survival after radical cystectomy and standardized extended lymphadenectomy for node-positive bladder cancer: prediction by lymph node positivity and density. BJU Int.104, 331–335 (2009).
   PubMed Web of Science ®Google Scholar
• Herr HW . Superiority of ratio based lymph node staging for bladder cancer. J. Urol.169, 943–945 (2003).
   PubMed Web of Science ®Google Scholar
• Osawa T , AbeT, ShinoharaNet al. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Int. J. Urol.16(3), 274–278; discussion 278 (2009).
   PubMed Web of Science ®Google Scholar
• Dziedzic D , PiotrR, LangfortRet al. Log odds of positive lymph nodes as a novel prognostic indicator in NSCLC staging. Surg. Oncol.26(1), 80–85 (2017).
   PubMed Web of Science ®Google Scholar
• Cronin KA , RiesLA, EdwardsBK. The Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. Cancer120(Suppl. 23), 3755–3757 (2014).
   PubMedGoogle Scholar
• DeLong ER , DeLongDM, Clarke-PearsonDL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics44, 837–845 (1988).
   PubMed Web of Science ®Google Scholar
• Pan W , BaiH. Propensity score interval matching: using bootstrap confidence intervals for accommodating estimation errors of propensity scores. BMC Med. Res. Methodol.15, 53 (2015).
   PubMed Web of Science ®Google Scholar
• Huang F , DUC, SunM, NingB, LuoY, AnS. [Propensity score matching in SPSS]. Nan Fang Yi Ke Da Xue Xue Bao35, 1597–1601 (2015).
   PubMedGoogle Scholar
• George B , SealsS, AbanI. Survival analysis and regression models. J. Nucl. Cardiol.21, 686–694 (2014).
   PubMed Web of Science ®Google Scholar
• Harrell FE Jr , CaliffRM, PryorDB, LeeKL, RosatiRA. Evaluating the yield of medical tests. JAMA247, 2543–2546 (1982).
   PubMed Web of Science ®Google Scholar
• Iasonos A , SchragD, RajGV, PanageasKS. How to build and interpret a nomogram for cancer prognosis. J. Clin. Oncol.26, 1364–1370 (2008).
   PubMed Web of Science ®Google Scholar
• Wolbers M , KollerMT, WittemanJC, SteyerbergEW. Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology20, 555–561 (2009).
   PubMed Web of Science ®Google Scholar
• Vickers AJ , ElkinEB. Decision curve analysis: a novel method for evaluating prediction models. Med. Decis. Making26, 565–574 (2006).
   PubMed Web of Science ®Google Scholar
• Charlton ME , AdamoMP, SunL, DeorahS. Bladder cancer collaborative stage variables and their data quality, usage, and clinical implications: a review of SEER data, 2004–2010. Cancer120(Suppl. 23), 3815–3825 (2014).
   PubMed Web of Science ®Google Scholar
• Coral RV , BigolinAV, CoralRP, HartmannA, DrankaC, RoeheAV. Metastatic lymph node ratio, 6th or 7th AJCC edition: witch is the best lymph node classification for esophageal cancer? Prognosis factor analysis in 487 patients. Arq. Bras. Cir. Dig.28(2), 94–97 (2015).
   PubMedGoogle Scholar
• Tan Z , MaG, YangH, ZhangL, RongT, LinP. Can lymph node ratio replace pn categories in the tumor-node-metastasis classification system for esophageal cancer?J. Thorac. Oncol.9, 1214–1221 (2014).
   PubMed Web of Science ®Google Scholar
• Zhang J , LvL, YeY, JiangK, ShenZ, WangS. Comparison of metastatic lymph node ratio staging system with the 7th AJCC system for colorectal cancer. J. Cancer Res. Clin. Oncol.139, 1947–1953 (2013).
   PubMed Web of Science ®Google Scholar
• Whitson JM , HarrisCR, ReeseAC, MengMV. Lymphadenectomy improves survival of patients with renal cell carcinoma and nodal metastases. J. Urol.185, 1615–1620 (2011).
   PubMedGoogle Scholar
• Yamashita K , HosodaK, EmaA, WatanabeM. Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer. Eur. J. Surg. Oncol.42, 1253–1260 (2016).
   PubMed Web of Science ®Google Scholar
• Riester M , TaylorJM, FeiferAet al. Combination of a novel gene expression signature with a clinical nomogram improves the prediction of survival in high-risk bladder cancer. Clin. Cancer Res.18, 1323–1333 (2012).
   PubMed Web of Science ®Google Scholar
• Bassi PF , BongiovanniL, RacioppiMet al. Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study. Urol. Oncol.29, 698–702 (2011).
   PubMed Web of Science ®Google Scholar
• Karakiewicz PI , ShariatSF, PalapattuGSet al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur. Urol.50, 1254–1260; discussion1261–1262 (2006).
   PubMed Web of Science ®Google Scholar
• Wakai K , UtsumiT, YonedaKet al. Development and external validation of a nomogram to predict high-grade papillary bladder cancer before first-time transurethral resection of the bladder tumor. Int. J. Clin. Oncol.23(5), 957–964 (2018).
   PubMed Web of Science ®Google Scholar
• Bachman AG , ParkerAA, ShawMDet al. Minimally invasive versus open approach for cystectomy: trends in the utilization and demographic or clinical predictors using the National Cancer Database. Urology103, 99–105 (2017).
   PubMed Web of Science ®Google Scholar
• Ismaili N , AmzerinM, FlechonA. Chemotherapy in advanced bladder cancer: current status and future. J. Hematol. Oncol.4, 35 (2011).
   PubMed Web of Science ®Google Scholar